Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Gait in Parkinson's Disease (PIGD)
NCT03011476Phase 4Unknown
- Sponsor
- Kyung Hee University Hospital
- Start
- Apr 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of donepezil in Parkinson's disease (PD) (2 arms), sponsored by Kyung Hee University Hospital. Primary endpoint: Positron emission tomography using 18F-flurodeoxyglucose at 12 weeks. Status: unknown.
02
Drugs
donepezil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03011476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03011476.